Yep, there might be a few traders hanging around a stock market forum, and not so many scientists. Funny about that.
Sorry some of us wonder about little things like why the travel budget for staff is equivalent to a third of the total revenue, why there's a projected $19.5m deficit this year, how they are going to increase sales tenfold in three years, and whether the projected revenue for 2018 is based on wildly optimistic assumptions - for CardioCel, 200 centres doing 120 procedures a year using 57,600 containers. And was the highly optimistic analysis of a 22c share price written by the company that has got the contract to do the AHZ capital raising, or have I got that wrong? And those Proactive Investor articles on the AHZ website are certainly glowing - wonder why there isn't a wider media coverage, as with Cynata?
And some of us might wonder why the company is burning through money so fast and why the banks aren't providing money for the rapid expansion. Why the shareholders again? (As mentioned it's either another capital raising or selling off assets, probably IP.) Also, why are there four times as many sellers as buyers ready for when the market opens?
Anyway, will leave you to it. Best wishes to all.
- Forums
- ASX - By Stock
- CardioCel - New Scientific Papers
Yep, there might be a few traders hanging around a stock market...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.81 |
Change
-0.190(1.90%) |
Mkt cap ! $208.2M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $45.11K | 4.596K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 814 | $9.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 813 | 9.710 |
2 | 480 | 9.700 |
1 | 180 | 9.690 |
1 | 180 | 9.680 |
1 | 180 | 9.670 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 554 | 1 |
9.990 | 432 | 3 |
10.000 | 794 | 2 |
10.500 | 10005 | 2 |
10.990 | 198 | 1 |
Last trade - 12.01pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online